Utility of Intrinsic Antitachycardia Pacing in Ventricular Tachycardia

JRCT ID: jRCTs032230043

Registered date:18/04/2023

Basic Information

• Recruitment status: Recruiting
• Health condition(s) or Problem(s) studied: Ventricular tachycardia
• Date of first enrollment: 23/04/2023
• Target sample size: 250
• Study type: Interventional
• Intervention(s): Patients will be assigned to single group. The first ATP therapy utilizes iATP and the second ATP therapy utilizes burst pacing (88%, 8 beats, 10 msec attenuation per sequence) .

Outcome(s)

• Primary Outcome: Termination rate of ventricular tachycardia by iATP therapy (the first set).
• Secondary Outcome: long-term sefety of the use of ICD

Key inclusion & exclusion criteria

• Age minimum: >= 18age old
• Age maximum: Not applicable
• Gender: Both
• Include criteria: Patinets, aged over 18 years old, who undergo ICD implantation or generator exchange at Tokai University Hospital and other institutes are included.
• Exclude criteria: Patients aged <18 years old, who refuse or unable to obtain consent to participate the study due to dementia or disturbance of consciousness, and are considered to be not eligible to paticipate the study by the investigators are excluded.

Related Information

• Primary Sponsor: Yagishita Atsuhiko
• Source(s) of Monetary Support: Metronic Japan